These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10817918)

  • 1. Glycosaminoglycans co-administration enhance insulin-like growth factor-I neuroprotective and neuroregenerative activity in traumatic and genetic models of motor neuron disease: a review.
    Di Giulio AM; Germani E; Lesma E; Muller E; Gorio A
    Int J Dev Neurosci; 2000; 18(4-5):339-46. PubMed ID: 10817918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscle reinnervation following neonatal nerve crush. Interactive effects of glycosaminoglycans and insulin-like growth factor-I.
    Gorio A; Vergani L; De Tollis A; Di Giulio AM; Torsello A; Cattaneo L; Muller EE
    Neuroscience; 1998 Feb; 82(4):1029-37. PubMed ID: 9466427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-administration of IGF-I and glycosaminoglycans greatly delays motor neurone disease and affects IGF-I expression in the wobbler mouse: a long-term study.
    Gorio A; Lesma E; Madaschi L; Di Giulio AM
    J Neurochem; 2002 Apr; 81(1):194-202. PubMed ID: 12067233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycosaminoglycans boost insulin-like growth factor-I-promoted neuroprotection: blockade of motor neuron death in the wobbler mouse.
    Vergani L; Losa M; Lesma E; Di Giulio AM; Torsello A; Müller EE; Gorio A
    Neuroscience; 1999; 93(2):565-72. PubMed ID: 10465440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotection, neuroregeneration, and interaction with insulin-like growth factor-I: novel non-anticoagulant action of glycosaminoglycans.
    Gorio A; Vergani L; Lesma E; Di Giulio AM
    J Neurosci Res; 1998 Mar; 51(5):559-62. PubMed ID: 9511999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of low doses of glycosaminoglycans and insulin-like growth factor-I on motor neuron disease in wobbler mouse.
    Vergani L; Finco C; Di Giulio AM; Muller EE; Gorio A
    Neurosci Lett; 1997 May; 228(1):41-4. PubMed ID: 9197283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycosaminoglycan-promoted muscle reinnervation and insulin-like growth factor-I levels are affected by anti-growth hormone-releasing hormone exposure.
    Gorio A; Citterio C; Muller EE; Di Giulio AM
    J Neurosci Res; 2001 Dec; 66(6):1112-7. PubMed ID: 11746443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycosaminoglycans treatment increases IGF-I muscle levels and counteracts motor neuron death: A novel nonanticoagulant action.
    Losa M; Vergani L; Lesma E; Rossoni G; Di Giulio AM; Vercelli A; Torsello A; Muller EE; Gorio A
    J Neurosci Res; 1999 Feb; 55(4):496-505. PubMed ID: 10723059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic administration of insulin-like growth factor decreases motor neuron cell death and promotes muscle reinnervation.
    Vergani L; Di Giulio AM; Losa M; Rossoni G; Muller EE; Gorio A
    J Neurosci Res; 1998 Dec; 54(6):840-7. PubMed ID: 9856868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial effects of insulin-like growth factor-I on wobbler mouse motoneuron disease.
    Hantaï D; Akaaboune M; Lagord C; Murawsky M; Houenou LJ; Festoff BW; Vaught JL; Rieger F; Blondet B
    J Neurol Sci; 1995 May; 129 Suppl():122-6. PubMed ID: 7595602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term neuroprotective effects of glycosaminoglycans-IGF-I cotreatment in the motor neuron degeneration (mnd) mutant mouse.
    Gorio A; Germani E; Lesma E; Rossoni G; Muller EE; Di Giulio AM
    Eur J Neurosci; 1999 Oct; 11(10):3395-404. PubMed ID: 10564347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor-I: potential for treatment of motor neuronal disorders.
    Lewis ME; Neff NT; Contreras PC; Stong DB; Oppenheim RW; Grebow PE; Vaught JL
    Exp Neurol; 1993 Nov; 124(1):73-88. PubMed ID: 8282084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention by insulin-like growth factor-I and riluzole in motor neuron death after neonatal axotomy.
    Iwasaki Y; Ikeda K
    J Neurol Sci; 1999 Oct; 169(1-2):148-55. PubMed ID: 10540024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscle reinnervation and IGF-I synthesis are affected by exposure to heparin: an effect partially antagonized by anti-growth hormone-releasing hormone.
    Madaschi L; Di Giulio AM; Gorio A
    Neurochem Res; 2003 Jan; 28(1):163-8. PubMed ID: 12587674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective effect of basic fibroblast growth factor on wobbler mouse motor neuron disease.
    Ikeda K; Iwasaki Y; Tagaya N; Shiojima T; Kobayashi T; Kinoshita M
    Neurol Res; 1995 Dec; 17(6):445-8. PubMed ID: 8622800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IGF-1: elixir for motor neuron diseases.
    Papanikolaou T; Ellerby LM
    Neuron; 2009 Aug; 63(3):277-8. PubMed ID: 19679066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coadministration of interleukin-6 (IL-6) and soluble IL-6 receptor delays progression of wobbler mouse motor neuron disease.
    Ikeda K; Kinoshita M; Tagaya N; Shiojima T; Taga T; Yasukawa K; Suzuki H; Okano A
    Brain Res; 1996 Jul; 726(1-2):91-7. PubMed ID: 8836549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effect of a novel free radical scavenger, OPC-14117, on wobbler mouse motor neuron disease.
    Abe K; Morita S; Kikuchi T; Itoyama Y
    J Neurosci Res; 1997 Apr; 48(1):63-70. PubMed ID: 9086182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation.
    Peviani M; Salvaneschi E; Bontempi L; Petese A; Manzo A; Rossi D; Salmona M; Collina S; Bigini P; Curti D
    Neurobiol Dis; 2014 Feb; 62():218-32. PubMed ID: 24141020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progesterone neuroprotection in the Wobbler mouse, a genetic model of spinal cord motor neuron disease.
    Gonzalez Deniselle MC; López-Costa JJ; Saavedra JP; Pietranera L; Gonzalez SL; Garay L; Guennoun R; Schumacher M; De Nicola AF
    Neurobiol Dis; 2002 Dec; 11(3):457-68. PubMed ID: 12586554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.